InvestorsHub Logo
Followers 38
Posts 2912
Boards Moderated 0
Alias Born 06/05/2012

Re: Lemoncat post# 368238

Sunday, 08/01/2021 1:15:37 PM

Sunday, August 01, 2021 1:15:37 PM

Post# of 402460
No.
1. I think there is good chance that Brilacidin will generate significantly more than $4B.
2. Even at sales of only $4B, a fairly conservative price/sales ratio of 12 would deliver a share price of over $100 per share.

So no, if this Phase 2 Covid trial is successful, I do not think that $10 per share is even close to a fair valuation.

Lemoncat said,

$4B in Remdesivir sale. …I think everyone would be pretty comfortable with a $10/share buyout, no?


"It is difficult to get a man to understand something, when his salary depends upon his not understanding it."

Upton Sinclair

Volume:
Day Range:
Bid:
Ask:
Last Trade Time:
Total Trades:
  • 1D
  • 1M
  • 3M
  • 6M
  • 1Y
  • 5Y
Recent IPIX News